Jaguar Gene Therapy is a clinical-stage biotechnology company dedicated to accelerating breakthroughs in Adeno-Associated Virus (AAV)-based gene therapy for patients afflicted with severe genetic diseases. The company focuses on conditions with high unmet medical needs, including galactosemia, specific genetic causes of autism spectrum disorder, and Type 1 diabetes. Jaguar Gene Therapy leverages an experienced management team with a strong track record in gene therapy development and commercialization to advance its novel therapeutic candidates through clinical trials and towards regulatory approval.
Serves as the central hub for strategic leadership, research and development (R&D) program management, clinical operations oversight, business development, and corporate administrative functions.
Located in a modern office park in the suburban Chicago area, providing access to a skilled talent pool and a strong life sciences ecosystem. The facility is designed to support both administrative and research coordination activities.
Jaguar Gene Therapy fosters a dynamic and patient-centric work culture focused on innovation, collaboration, and scientific rigor. Employees are driven by the mission to develop life-changing gene therapies for severe genetic diseases.
The Lake Forest headquarters is strategically important due to its proximity to Chicago's biotechnology cluster, facilitating access to talent, research institutions, and potential partners essential for advancing Jaguar's gene therapy pipeline.
Currently, Jaguar Gene Therapy's primary physical operations, including its headquarters and manufacturing facility, are based in the United States (Illinois and North Carolina). However, the company's mission to treat severe genetic diseases has a global scope. Their research, clinical development programs, and future commercialization strategies are designed to address patient needs worldwide, potentially involving international clinical trial sites and partnerships.
100 North Field Drive, Suite 160
Lake Forest
Illinois
USA
Address: 101 JGN Drive, Cary, NC 27519 (Custom address for their manufacturing facility)
Strategically located near the Research Triangle Park (RTP), this site benefits from access to a dense ecosystem of biotech talent, specialized suppliers, and research institutions crucial for advanced biologics manufacturing and development.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Jaguar Gene Therapy' leadership includes:
Jaguar Gene Therapy has been backed by several prominent investors over the years, including:
Over the past 12 months (May 2023 - May 2024), Jaguar Gene Therapy has significantly strengthened its executive leadership by appointing a new CFO, CCO, CSO, and CPO. There was also a key transition involving a co-founder stepping down from executive R&D roles while remaining on the Board.
Discover the tools Jaguar Gene Therapy uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
While Jaguar Gene Therapy's exact email format is not publicly confirmed, companies in the biotechnology sector commonly use formats like first initial followed by last name, or first name separated by a dot from the last name, preceding '@jaguargenetherapy.com'.
[first_initial][last]@jaguargenetherapy.com
Format
jdoe@jaguargenetherapy.com
Example
70%
Success rate
Business Wire • March 12, 2024
Jaguar Gene Therapy announced the appointment of Catherine (Katie) Rosenberg as its Chief People Officer. She will be responsible for leading all aspects of human resources, including talent acquisition, learning and development, compensation and benefits, and fostering company culture....more
Business Wire • November 2, 2023
Jaguar Gene Therapy announced the appointment of Samuel Wadsworth, Ph.D., as Chief Scientific Officer and the transition of co-founder Suma Krishnan, M.D., from her executive roles to continue serving on the Board of Directors. The company also reported securing an additional $100 million in financing from current investors....more
Business Wire • October 26, 2023
Jaguar Gene Therapy announced it has strengthened its executive leadership team with the appointments of David W.G. Smith, Ph.D., as Chief Financial Officer and Chris BadRequest as Chief Commercial Officer, enhancing its capabilities as it advances its pipeline....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Jaguar Gene Therapy, are just a search away.